Immunohistochemical expression of muscarinic receptors in the urothelium and suburothelium of neurogenic and idiopathic overactive human bladders, and changes with botulinum neurotoxin administration

Journal of Urology

Volumn 184, Issue 6, 2010, Pages 2578-2585

  Datta, Soumendra N ^a,b   Roosen, Alexander ^a,e   Pullen, Antony ^a   Popat, Roshni ^b   Rosenbaum, Tomas P ^c   Elneil, Sohier ^b   Dasgupta, Prokar ^b,d   Fowler, Clare J ^a,b   Apostolidis, Apostolos ^a,f  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d GUY S HOSPITAL   (United Kingdom)

^e UNIVERSITY OF MUNICH   (Germany)

^f ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Botulinum toxins; Receptors muscarinic; Urinary bladder; Urinary bladder overactive; Urination disorders

Indexed keywords

BOTULINUM TOXIN A; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR;

ADULT; ARTICLE; BLADDER BIOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTOSCOPY; HEMATURIA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NEUROGENIC BLADDER; OVERACTIVE BLADDER; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SYMPTOM; TREATMENT DURATION; UROTHELIUM;

BOTULINUM TOXINS, TYPE A; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEUROMUSCULAR AGENTS; RECEPTORS, MUSCARINIC; URINARY BLADDER, NEUROGENIC; URINARY BLADDER, OVERACTIVE; UROTHELIUM;

EID: 78349307168     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2010.07.034     Document Type: Article

References (29)

1. T. Bschleipfer, K. Schukowski, and W. Weidner Expression and distribution of cholinergic receptors in the human urothelium Life Sci 80 2007 2303
2. M. Yoshida, A. Inadome, and Y. Maeda Non-neuronal cholinergic system in human bladder urothelium Urology 67 2006 425
3. G. Mukerji, Y. Yiangou, and J. Grogono Localization of M2 and M3 muscarinic receptors in human bladder disorders and their clinical correlations J Urol 176 2006 367
4. K.J. Mansfield, L. Liu, and F.J. Mitchelson Muscarinic receptor subtypes in human bladder detrusor and mucosa, studied by radioligand binding and quantitative competitive RT-PCR: changes in ageing Br J Pharmacol 144 2005 1089
5. S. Tyagi, P. Tyagi, and S. Van-le Qualitative and quantitative expression profile of muscarinic receptors in human urothelium and detrusor J Urol 176 2006 1673
6. S.M. Finney, K.E. Andersson, and J.I. Gillespie Antimuscarinic drugs in detrusor overactivity and the overactive bladder syndrome: motor or sensory actions? BJU Int 98 2006 503
7. J.C. Kim, J.S. Yoo, and E.Y. Park Muscarinic and purinergic receptor expression in the urothelium of rats with detrusor overactivity induced by bladder outlet obstruction BJU Int 101 2008 371
8. Y. Kim, N. Yoshimura, and H. Masuda Antimuscarinic agents exhibit local inhibitory effects on muscarinic receptors in bladder-afferent pathways Urology 65 2005 238
9. K.J. Mansfield, L. Liu, and K.H. Moore Molecular characterization of M2 and M3 muscarinic receptor expression in bladder from women with refractory idiopathic detrusor overactivity BJU Int 99 2007 1433
10. C. Wu, G.P. Sui, and C.H. Fry Purinergic regulation of guinea pig suburothelial myofibroblasts J Physiol 559 2004 231
11. A.S. Anisuzzaman, S. Morishima, and F. Suzuki Assessment of muscarinic receptor subtypes in human and rat lower urinary tract by tissue segment binding assay J Pharmacol Sci 106 2008 271
12. B. Schurch, M. Stohrer, and G. Kramer Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results J Urol 164 2000 692
13. L. Brubaker, H.E. Richter, and A. Visco Refractory idiopathic urge urinary incontinence and botulinum A injection J Urol 180 2008 217
14. A. Sahai, M.S. Khan, and P. Dasgupta Efficacy of botulinum toxin-A for treating idiopathic detrusor overactivity: results from a single center, randomized, double-blind, placebo controlled trial J Urol 177 2007 2231
15. A. Apostolidis, P. Dasgupta, and C.J. Fowler Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity Eur Urol 49 2006 644
16. R. Popat, A. Apostolidis, and V. Kalsi A comparison between the response of patients with idiopathic detrusor overactivity and neurogenic detrusor overactivity to the first intradetrusor injection of botulinum-A toxin J Urol 174 2005 984
17. A. Apostolidis, R. Popat, and Y. Yiangou Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity J Urol 174 2005 977
18. S.Y. Shu, G. Ju, and L.Z. Fan The glucose oxidase-DAB-nickel method in peroxidase histochemistry of the nervous system Neurosci Lett 85 1988 169
19. B.A. Habecker, and N.M. Nathanson Regulation of muscarinic acetylcholine receptor mRNA expression by activation of homologous and heterologous receptors Proc Natl Acad Sci U S A 89 1992 5035
20. N.H. Lee, J. Earle-Hughes, and C.M. Fraser Agonist-mediated destabilization of m1 muscarinic acetylcholine receptor mRNA Elements involved in mRNA stability are localized in the 3′-untranslated region J Biol Chem 269 1994 4291
21. M. Yoshida, K. Miyamae, and H. Iwashita Management of detrusor dysfunction in the elderly: changes in acetylcholine and adenosine triphosphate release during aging Urology 63 2004 17
22. S.C. Harrison, G.R. Hunnam, and P. Farman Bladder instability and denervation in patients with bladder outflow obstruction Br J Urol 60 1987 519
23. W.H. Turner, and A.F. Brading Smooth muscle of the bladder in the normal and the diseased state: pathophysiology, diagnosis and treatment Pharmacol Ther 75 1997 77
24. J. Rousell, E.B. Haddad, and J.C. Mak Transcriptional down-regulation of m2 muscarinic receptor gene expression in human embryonic lung (HEL 299) cells by protein kinase C J Biol Chem 270 1995 7213
25. E.B. Haddad, J. Rousell, and J.C. Mak Long-term carbachol treatment-induced down-regulation of muscarinic M2-receptors but not m2 receptor mRNA in a human lung cell line Br J Pharmacol 116 1995 2027
26. C.P. Smith, D.A. Gangitano, and A. Munoz Botulinum toxin type A normalizes alterations in urothelial ATP and NO release induced by chronic spinal cord injury Neurochem Int 52 2008 1068
27. G.T. Somogyi, and W.C. de Groat Function, signal transduction mechanisms and plasticity of presynaptic muscarinic receptors in the urinary bladder Life Sci 6 1999 411
28. D.M. Daly, R. Chess-Williams, and C. Chapple The inhibitory role of acetylcholine and muscarinic receptors in bladder afferent activity Eur Urol 2010 Epub ahead of print
29. W. Pradidarcheep, J. Stallen, and W.T. Labruyere Lack of specificity of commercially available antisera against muscarinergic and adrenergic receptors Naunyn Schmiedebergs Arch Pharmacol 379 2009 397